| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |